Emergent Biosolutions Inc (NYSE: EBS) is 305.00% higher on its value in year-to-date trading and has touched a low of $1.42 and a high of $15.10 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The EBS stock was last observed hovering at around $10.11 in the last trading session, with the day’s loss setting it -0.39%.
Currently trading at $9.72, the stock is -15.60% and 16.69% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.76 million and changing -3.86% at the moment leaves the stock 147.54% off its SMA200. EBS registered 35.00% gain for a year compared to 6-month gain of 500.00%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 22.57% loss in the last 1 month and extending the period to 3 months gives it a 149.87%, and is -34.19% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 21.59% over the week and 12.68% over the month.
Emergent Biosolutions Inc (EBS) has around 1600 employees, a market worth around $509.33M and $1.19B in sales. Profit margin for the company is -47.68%. Distance from 52-week low is 584.51% and -35.63% from its 52-week high. The company has generated returns on investments over the last 12 months (-50.30%).
The EPS is expected to grow by 67.66% this year.
Emergent Biosolutions Inc (EBS) Top Institutional Holders
The shares outstanding are 52.20M, and float is at 50.15M with Short Float at 9.10%.
Emergent Biosolutions Inc (EBS) Insider Activity
The most recent transaction is an insider sale by Zoon Kathryn C,the company’sDirector. SEC filings show that Zoon Kathryn C sold 10,000 shares of the company’s common stock on Jun 04 ’24 at a price of $6.11 per share for a total of $61100.0. Following the sale, the insider now owns 54482.0 shares.
Emergent Biosolutions Inc disclosed in a document filed with the SEC on May 29 ’24 that Zoon Kathryn C (Director) sold a total of 1,830 shares of the company’s common stock. The trade occurred on May 29 ’24 and was made at $4.61 per share for $8436.0. Following the transaction, the insider now directly holds 64482.0 shares of the EBS stock.
Still, SEC filings show that on May 21 ’24, Zoon Kathryn C (Director) disposed off 1,089 shares at an average price of $5.78 for $6294.0. The insider now directly holds 48,882 shares of Emergent Biosolutions Inc (EBS).
